SF
PPH icon

Synovus Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Synovus Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-162
Closed -$10K – 1064
2014
Q4 		$10K Buy
+162
New +$10.3K ﹤0.01% 871

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Synovus Financial's PPH Position: Q1 2015 in Review

Synovus Financial sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2015, closing a stake of 162 shares — an estimated $10K sold.

Synovus Financial first reported a position in PPH in Q4 2014 and held it in 1 quarter. The position peaked at $10K in Q4 2014. 52 funds tracked by Wall St. Rank hold PPH as of Q1 2015.

  • Synovus Financial reported no remaining VanEck Pharmaceutical ETF position as of Q1 2015 after selling out during the quarter.
  • Synovus Financial sold 162 VanEck Pharmaceutical ETF shares in Q1 2015, an estimated $10K.
  • Synovus Financial first reported a position in VanEck Pharmaceutical ETF in Q4 2014 and held it in 1 quarter.
  • Synovus Financial's VanEck Pharmaceutical ETF position peaked at $10K in Q4 2014.
  • 52 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2015.

Based on Synovus Financial's 13F filing for Q1 2015, filed 8 May 2015.